Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

This study has been completed.
Eli Lilly and Company
Genentech, Inc.
Information provided by (Responsible Party):
University of Pittsburgh Identifier:
First received: June 20, 2008
Last updated: February 17, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)